يعرض 1 - 20 نتائج من 79 نتيجة بحث عن '"Tewari, K.S."', وقت الاستعلام: 0.56s تنقيح النتائج
  1. 1
    Academic Journal

    المساهمون: University of Arizona College of Medicine, Phoenix, Honor Health Research Institute, University of Arizona, Creighton University, Phoenix, AZ

    المصدر: Cancer control : journal of the Moffitt Cancer Center

    Relation: Richardson MT, Attwood K, Smith G, et al. Sequential Targeted Therapy for Advanced, Metastatic, and Recurrent Cervical Cancer: A Cost-Effectiveness Analysis of the Patient Journey. Cancer Control. 2023;30. doi:10.1177/10732748231182795; http://hdl.handle.net/10150/672125; Cancer control : journal of the Moffitt Cancer Center

  2. 2
  3. 3
    Academic Journal

    المساهمون: HonorHealth Research Institute, University of Arizona

    المصدر: Journal of Clinical Oncology

    Relation: You, B., Purdy, C., Copeland, L. J., Swisher, E. M., Bookman, M. A., Fleming, G., . & Burger, R. A. (2022). Identification of patients with ovarian cancer experiencing the highest benefit from bevacizumab in the first-line setting on the basis of their tumor-intrinsic chemosensitivity (KELIM): the GOG-0218 validation study. Journal of clinical oncology, 40(34), 3965.; http://hdl.handle.net/10150/670409; Journal of Clinical Oncology

  4. 4
  5. 5
  6. 6
    Conference

    المصدر: Swisher , E M , Coleman , R L , Bookman , M A , Brady , M F , Fleming , G F , Friedlander , M , Cunningham , J , Tewari , K S , Edraki , B , Mantia-Smaldone , G M , Ratajczak , C K , Dinh , M H , Sullivan , D M , McClain , S , Okubo , S , Dahl Steffensen , K & Aghajanian , C 2020 , ' Safety of veliparib in combination with chemotherapy and as maintenance in front-line ovarian cancer: Results in BRCAm, hrd, ....

  7. 7
  8. 8
  9. 9
    Academic Journal
  10. 10
  11. 11
  12. 12
    Academic Journal
  13. 13

    المساهمون: Obstetrie & Gynaecologie, MUMC+: MA Medische Staf Obstetrie Gynaecologie (9), RS: GROW - R2 - Basic and Translational Cancer Biology, Obstetrics and gynaecology, Amsterdam Reproduction & Development (AR&D), Targeted Gynaecologic Oncology (TARGON), Cancer Center Amsterdam, Obstetrics and Gynaecology, CCA - Cancer Treatment and Quality of Life, Gynecological Oncology

    المصدر: Gynecologic Oncology, 167(1), 3-10. Elsevier Science
    Gynecologic Oncology, 167(1), 3-10. Academic Press Inc.
    Gynecologic Oncology, 167(1). ACADEMIC PRESS INC ELSEVIER SCIENCE
    Gynecologic oncology, 167(1), 3-10. Academic Press Inc.
    On behalf of all GROINSS-V I and II participants 2022, ' Unilateral inguinofemoral lymphadenectomy in patients with early-stage vulvar squamous cell carcinoma and a unilateral metastatic sentinel lymph node is safe ', Gynecologic Oncology, vol. 167, no. 1, pp. 3-10 . https://doi.org/10.1016/j.ygyno.2022.07.017
    Gynecologic Oncology, 167, 3-10
    Gynecologic Oncology, 167(1), 3-10. ACADEMIC PRESS INC ELSEVIER SCIENCE
    Gynecologic Oncology, 167(1), 3-10. Academic Press
    Gynecologic Oncology, 167, 1, pp. 3-10
    Van der Kolk, W L, Van der Zee, A G J, Slomovitz, B M, Baldwin, P J W, Van Doorn, H C, De Hullu, J A, Van der Velden, J, Gaarenstroom, K N, Slangen, B F M, Kjolhede, P, Brännström, M, Vergote, I, Holland, C M, Coleman, R, Van Dorst, E B L, Van Driel, W J, Nunns, D, Widschwendter, M, Nugent, D, DiSilvestro, P A, Mannel, R S, Tjiong, M Y, Boll, D, Cibula, D, Covens, A, Provencher, D, Runnebaum, I B, Monk, B J, Zanagnolo, V, Tamussino, K, Oonk, M H M & On behalf of all GROINSS-V I and II participants 2022, ' Unilateral inguinofemoral lymphadenectomy in patients with early-stage vulvar squamous cell carcinoma and a unilateral metastatic sentinel lymph node is safe ', Gynecologic Oncology, vol. 167, no. 1, pp. 3-10 . https://doi.org/10.1016/j.ygyno.2022.07.017

    وصف الملف: application/pdf; Print-Electronic

  14. 14
    Academic Journal
  15. 15
    Academic Journal

    المصدر: Journal of Clinical Oncology, 39, 32, pp. 3623-3632

  16. 16
    Academic Journal
  17. 17
  18. 18
  19. 19
    Academic Journal
  20. 20